114
Participants
Start Date
June 30, 2004
Primary Completion Date
September 30, 2007
Study Completion Date
May 31, 2011
MRK Ad5 HIV-1 gag vaccine
MRK Ad5 HIV-1 gag vaccine injected into the upper arm muscle.
Vaccine placebo
MRK Ad5 HIV-1 gag placebo vaccine injected into the upper arm muscle.
Beth Israel Med. Ctr., ACTU, New York
NY Univ. HIV/AIDS CRS, New York
Cornell CRS, New York
AIDS Care CRS, Rochester
Univ. of Rochester ACTG CRS, Rochester
Pitt CRS, Pittsburgh
IHV Baltimore Treatment CRS, Baltimore
Unc Aids Crs, Chapel Hill
Univ. of Miami AIDS CRS, Miami
The Ohio State University Medical Center, Columbus
Case CRS, Cleveland
MetroHealth CRS, Cleveland
University of Minnesota, ACTU, Minneapolis
Rush Univ. Med. Ctr. ACTG CRS, Chicago
Washington U CRS, St Louis
UCLA CARE Center CRS, Los Angeles
Ucsd, Avrc Crs, San Diego
Ucsf Aids Crs, San Francisco
Univ. of California Davis Med. Ctr., ACTU, Sacramento
Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu
University of Washington AIDS CRS, Seattle
Stanford CRS, Palo Alto
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
Massachusetts General Hospital ACTG CRS, Boston
Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston
The Miriam Hosp. ACTG CRS, Providence
Univ. of Texas Medical Branch, ACTU, Galveston
Puerto Rico-AIDS CRS, San Juan
National Institute of Allergy and Infectious Diseases (NIAID)
NIH